Teva Pharmaceutical Industries (NYSE:TEVA) Lifted to Hold at Zacks Investment Research

Share

BTIG Research raised shares of Teva Pharmaceutical Industries from a "neutral" rating to a "buy" rating and set a $24.00 price objective for the company in a report on Monday, September 11th. The Company is engaged in developing, producing and marketing generic medicines and a portfolio of specialty medicines. The weekly volatility was 2.52% for Teva Pharmaceutical Industries Limited, TEVA, making it easy for the traders to interpret how riskier their investment is on this stock. About 20.19M shares traded. Net profit margin of Teva Pharmaceutical Industries Limited (TEVA) was recorded at -25.5 percent, operating profit margin was -19.7 percent, while gross profit margin stands at 49.8 percent. It has underperformed by 58.40% the S&P500.The move comes after 9 months positive chart setup for the $20.36 billion company.

Thompson Siegel & Walmsley Llc increased its stake in Sp Plus Corp (SP) by 21.4% based on its latest 2017Q3 regulatory filing with the SEC. The company has managed to keep price to sales ratio of 0.82. Silchester International Investors Llp who had been investing in Kt Corp for a number of months, seems to be bullish on the $6.85 billion market cap company. It closed at $37.65 lastly. Apple Inc. (NASDAQ:AAPL) has risen 62.48% since January 10, 2017 and is uptrending. About 12.06 million shares traded.

Among 33 analysts covering Teva Pharma (NYSE:TEVA), 8 have Buy rating, 7 Sell and 18 Hold. Therefore 75% are positive. The legal version of this report can be accessed at https://www.dispatchtribunal.com/2018/01/10/teva-pharmaceutical-industries-teva-given-a-10-00-price-target-by-cantor-fitzgerald-analysts.html. $9.98 million worth of stock was sold by FEDERIGHI CRAIG on Monday, August 7. The stock has "Hold" rating by Morgan Stanley on Friday, December 15. RBC Capital Markets maintained the stock with "Underperform" rating in Friday, November 3 report. The stock of Teva Pharmaceutical Industries Limited (NYSE:TEVA) earned "Neutral" rating by JP Morgan on Friday, January 20. RBC Capital Markets maintained Teva Pharmaceutical Industries Limited (NYSE:TEVA) rating on Wednesday, November 29. Maxim Group maintained the stock with "Buy" rating in Wednesday, November 16 report. -5.87 EPS for Teva Pharmaceutical Industries Limited shows how profitable the company is alongside the other key metrics such as volatility. Jefferies has "Hold" rating and $3300 target. The firm has "Neutral" rating by Credit Suisse given on Wednesday, May 4. Moreover, Corda Invest Mgmt Limited Company has 3.48% invested in Johnson & Johnson (NYSE:JNJ). Bronfman E.L. Rothschild L.P. now owns 3,711 shares of the company's stock valued at $123,000 after acquiring an additional 94 shares in the last quarter.

Analysts await Teva Pharmaceutical Industries Limited (NYSE:TEVA) to report earnings on February, 12.

Investors sentiment decreased to 1.75 in 2017 Q3. 67 funds opened positions while 169 raised stakes. Bernzott Advsr reported 4.86% stake. Deprince Race & Zollo Inc owns 792,932 shares or 0.22% of their U.S. portfolio. 279.18 million shares or 0.29% more from 278.36 million shares in 2017Q2 were reported. Lingohr Partner Asset Mngmt Gmbh invested in 0.5% or 69,500 shares. Srouji Johny sold $1.70 million worth of stock or 10,469 shares. Chicago Equity Ltd Llc stated it has 0.06% of its portfolio in SP Plus Corporation (NASDAQ:SP). Asset Inc reported 1.02% stake. Arrowmark Colorado Holding Limited Liability Co invested in 0.48% or 1.08 million shares. Denver Inv Advsr Ltd holds 0.36% in Johnson & Johnson (NYSE:JNJ) or 56,235 shares. Assetmark Inc holds 0.05% or 345,011 shares.

Health club chain quitting cable news on big-screen TVs
There are Life Time gyms in Rockville, Maryland; Gaithersburg, Maryland; Columbia, Maryland; Fairfax, Virginia; and Reston, Virginia.

Tieton Capital Management Llc holds 3.41% of its portfolio in TESSCO Technologies Incorporated for 318,499 shares. Suntrust Banks holds 7,847 shares.

Among 2 analysts covering SP Plus (NASDAQ:SP), 2 have Buy rating, 0 Sell and 0 Hold. Therefore 27% are positive.

The company's Average Revenue Estimate for the current quarter is $4.94 Billion, while Low and High Revenue Estimates are $4.62 Billion and $5.22 Billion respectively. As per Wednesday, September 6, the company rating was maintained by JMP Securities. Deutsche Bank maintained the shares of TEVA in report on Tuesday, July 28 with "Buy" rating.

Sol Capital Management Co decreased Ishares Dj Us Home Constructio (ITB) stake by 26,871 shares to 157,732 valued at $5.76M in 2017Q3. It also reduced its holding in Visa Inc Class A Shares (NYSE:V) by 13,725 shares in the quarter, leaving it with 413,092 shares, and cut its stake in Mcdermott Intl Inc (NYSE:MDR).

Share